CureMatch, Inc.

CureMatch, Inc. is a promising AI-based Precision Medicine startup focused on providing digital decision support solutions for oncology. Established in 2015 and headquartered in the United States, the company's slogan "AI-based Precision Medicine Decision Support for Oncology" succinctly encapsulates their mission. Their Decision Support System leverages AI algorithms and world-class research to empower oncologists in understanding personalized therapeutic options tailored to each patient's unique molecular profile. Notably, the startup received a substantial Venture Round investment on 27 October 2017, with Serra Ventures backing their innovative approach. As the healthcare industry continues to embrace the potential of AI in precision medicine, CureMatch, Inc. stands as a promising player offering sophisticated solutions to enhance cancer treatment through personalized and data-driven strategies.